Celldex Therapeutics Inc · Operating Cash Flow (Statement)

Latest reported-$57.41Mperiod endingJun 30, 2026

CLDX Quarterly Cash from Operations ($1.80M → -$57.41M)

Quarterly operating cash flow (statement)

High-resolution chart · PNG

CLDX operating cash flow (statement) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Celldex Therapeutics Inc Operating Cash Flow (Statement) — Quarterly (USD)
Period ending	Operating Cash Flow (Statement) (USD)
Jun 30, 2001	-4,338,100
Mar 31, 2001	-5,269,500
Dec 31, 2000	-287,200
Sep 30, 2000	-2,515,100
Jun 30, 2000	-2,826,500
Mar 31, 2000	1,196,900
Dec 31, 1999	-1,239,100
Sep 30, 1999	-2,400,000
Jun 30, 1999	-2,500,000
Mar 31, 1999	-2,400,000
Dec 31, 1998	-1,100,000
Sep 30, 1998	-3,800,000
Jun 30, 1998	-2,100,000
Mar 31, 1998	-1,900,000
Dec 31, 1997	-2,100,000
Sep 30, 1997	-2,000,000
Jun 30, 1997	-1,500,000
Mar 31, 1997	-2,100,000
Dec 31, 1996	-1,900,000
Sep 30, 1996	-2,500,000
Jun 30, 1996	-2,600,000
Mar 31, 1996	-2,700,000
Dec 31, 1995	900,000
Sep 30, 1995	-3,300,000
Jun 30, 1995	-2,400,000
Mar 31, 1995	-3,100,000
Dec 31, 1994	-2,700,000
Sep 30, 1994	-2,000,000
Jun 30, 1994	-2,400,000
Mar 31, 1994	-2,000,000
Dec 31, 1993	-1,000,000
Sep 30, 1993	-1,200,000
Jun 30, 1993	-1,700,000
Mar 31, 1993	-1,600,000
Oct 31, 1992	-1,500,000
Jul 31, 1992	-1,100,000
Apr 30, 1992	-1,300,000
Jan 31, 1992	-500,000
Oct 31, 1991	-1,500,000
Jul 31, 1991	-800,000
Apr 30, 1991	-100,000
Jan 31, 1991	-1,000,000
Oct 31, 1990	-1,600,000
Jul 31, 1990	-300,000
Apr 30, 1990	1,800,000